1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

23 Dec 2023
Admin
News Article

Anti-cold drug combination banned for kids under 4 years: All you need to know

The use of an anti-cold fixed drug combination has been prohibited by the Indian drugs regulator Central Drugs Standard Control Organisation (CDSCO) to be used for children under the age of 4.

This common cold fixed drug combination (FDC) is a cocktail of two drugs, chlorpheniramine maleate and phenylephrine.

This decision was made based on the recommendations of the Subject Expert Committee (SEC) which emphasised that this drug combination should not be used for children below four years of age.All manufacturers of this common cold fixed-dose combination (FDC), containing chlorpheniramine maleate IP 2mg with phenylephrine HCL IP 5 mg per ml drops, have been directed to include a warning on the label and the package about the caution: “FDC should not be used in children below 4 years of age.”The order by the regulator on the fixed-drug combination was issued on December 18 and made public on Wednesday.

All about this anti-cold fixed drug combination

This anti-cold drug combination contains chlorpheniramine maleate and phenylephrine. While chlorpheniramine maleate is an anti-allergic drug (antihistamine), phenylephrine is a decongestant.

According to Cleveland Clinic, this drug combination helps treat symptoms of common cold or sinus inflammation. It can help relieve runny nose, sneezing and congestion in the nose. However, this medicine will not treat an infection.n case you’re consuming this drug formulation, do not increase the recommended dose as it could result in serious harm such as hallucinations, seizure and death,

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!